Abie Alias, Ernesto J Rodriguez, Helen E Bateman, Ashley G Sterrett, Joanne Valeriano-Marcet
{"title":"Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy.","authors":"Abie Alias, Ernesto J Rodriguez, Helen E Bateman, Ashley G Sterrett, Joanne Valeriano-Marcet","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Review of the literature addressing the rheumatic manifestations of various malignancies as well as of common chemotherapeutic agents.</p><p><strong>Methods: </strong>A literature search was performed to identify key articles regarding the association of rheumatic disease with malignancy.</p><p><strong>Results: </strong>Our review focused on the association of rheumatic disease with malignancy, paraneoplastic syndromes with rheumatic manifestations, and chemotherapeutic agents related to rheumatic syndromes. We have discussed the importance of a newly described autoantibody that may identify patients at risk for malignancy associated myositis.</p><p><strong>Conclusion: </strong>Based on our literature review, recommendations are suggested regarding who and how patients should be screened for malignancy when presenting with various rheumatic symptoms.</p>","PeriodicalId":72485,"journal":{"name":"Bulletin of the NYU hospital for joint diseases","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of the NYU hospital for joint diseases","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Review of the literature addressing the rheumatic manifestations of various malignancies as well as of common chemotherapeutic agents.
Methods: A literature search was performed to identify key articles regarding the association of rheumatic disease with malignancy.
Results: Our review focused on the association of rheumatic disease with malignancy, paraneoplastic syndromes with rheumatic manifestations, and chemotherapeutic agents related to rheumatic syndromes. We have discussed the importance of a newly described autoantibody that may identify patients at risk for malignancy associated myositis.
Conclusion: Based on our literature review, recommendations are suggested regarding who and how patients should be screened for malignancy when presenting with various rheumatic symptoms.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
